← back to search

Harry K. Genant

University of California, San Francisco · US
Area of research
Orthopedics and Sports Medicine · Oncology
Research interest
Research interests include Bone health and osteoporosis research, Bone and Joint Diseases, Bone health and treatments, and Rheumatoid Arthritis Research and Therapies.
h-index
146
citations
88,690
works
870
NIH funding
primary concept
email

Recent publications

Effects of the anti-RANKL antibody denosumab on joint structural damage in patients with rheumatoid arthritis treated with conventional synthetic disease-modifying antirheumatic drugs (DESIRABLE study): a randomised, double-blind, placebo-controlled phase 3 trial
Annals of the Rheumatic Diseases 2019cited by 136position: middledoi
Longitudinal Reliability of the OMERACT Thumb Base Osteoarthritis Magnetic Resonance Imaging Scoring System (TOMS).
2019cited by 5position: contributordoi
Non-invasive DXA-derived bone structure assessment of acromegaly patients: a cross-sectional study
European Journal of Endocrinology 2018cited by 62position: middledoi
Romosozumab (sclerostin monoclonal antibody) versus teriparatide in postmenopausal women with osteoporosis transitioning from oral bisphosphonate therapy: a randomised, open-label, phase 3 trial
The Lancet 2017cited by 461position: middledoi
Spine fracture prevalence in a nationally representative sample of US women and men aged ≥40 years: results from the National Health and Nutrition Examination Survey (NHANES) 2013-2014
Osteoporosis International 2017cited by 120position: lastdoi
Effect of denosumab on Japanese patients with rheumatoid arthritis: a dose–response study of AMG 162 (Denosumab) in patients with RheumatoId arthritis on methotrexate to Validate inhibitory effect on bone Erosion (DRIVE)—a 12-month, multicentre, randomised, double-blind, placebo-controlled, phase II clinical trial
Annals of the Rheumatic Diseases 2016cited by 162position: middledoi
Effects of Romosozumab Compared With Teriparatide on Bone Density and Mass at the Spine and Hip in Postmenopausal Women With Low Bone Mass
Journal of Bone and Mineral Research 2016cited by 140position: firstdoi
Reduced Bone Density and Vertebral Fractures in Smokers. Men and COPD Patients at Increased Risk
Annals of the American Thoracic Society 2015cited by 118position: middledoi
Relationship Between Vertebral Fracture Burden, Height Loss, and Pulmonary Function in Postmenopausal Women With Osteoporosis
Journal of Clinical Densitometry 2015cited by 58position: middledoi
Maintenance of remission following 2 years of standard treatment then dose reduction with abatacept in patients with early rheumatoid arthritis and poor prognosis
Annals of the Rheumatic Diseases 2014cited by 43position: middledoi
Femoral and Vertebral Strength Improvements in Postmenopausal Women With Osteoporosis Treated With Denosumab
Journal of Bone and Mineral Research 2013cited by 116position: middledoi
MRI of bone marrow abnormalities in hematological malignancies
Diagnostic and Interventional Radiology 2013cited by 43position: middledoi
Efficacy and safety of strontium ranelate in the treatment of knee osteoarthritis: results of a double-blind, randomised placebo-controlled trial
Annals of the Rheumatic Diseases 2012cited by 290position: middledoi
New advances in imaging osteoporosis and its complications
Endocrine 2012cited by 99position: lastdoi

Grants

No grants ingested yet.

Frequent collaborators

Stefan Goemaere · Lund University3 papers (2013–2017)Klaus Engelke · Friedrich-Alexander-Universität Erlangen-Nürnberg3 papers (2013–2017)Cesar Libanati · Amgen (United States)3 papers (2013–2017)David L. Kendler · University of British Columbia3 papers (2013–2017)Jacques P. Brown · Université Laval3 papers (2013–2017)Michael A. Bolognese · Amgen (United States)2 papers (2016–2017)Chris Recknor · Amgen (United States)2 papers (2013–2016)Tony M. Keaveny · University of California, Berkeley2 papers (2013–2017)Hisashi Yamanaka · Sanno Medical Center2 papers (2016–2019)Kelly Krohn · University of Arizona2 papers (2015–2017)Toshiyuki Yoneda · Indiana University School of Medicine2 papers (2016–2019)Tsutomu Takeuchi · Keio University2 papers (2016–2019) · 2 papers (2016–2019)Désirée van der Heijde · Leiden University2 papers (2016–2019)Thomas Fuerst · Friedrich-Alexander-Universität Erlangen-Nürnberg2 papers (2013–2016)Andreas Grauer · Amgen (United States)2 papers (2016–2017)Yoshiya Tanaka · Chukyo Hospital2 papers (2016–2019)Hoi-Shen Radcliffe · Amgen (United States)1 papers (2013–2013)Judy Maddox · Amgen (United States)1 papers (2017–2017) · 1 papers (2018–2018)